Table of contents :
Culture medium : a substance used to support the growth of microorganisms or other cells. They can be classified according to ...
|
|
|
|
| CaCl2 (anhydrous) | 200.00 | 140.04 |
| KCl | 400.00 | 400.00 |
| KH2PO4 | - | 60.00 |
| MgSO4 (anhydrous) | 97.67 | 97.70 |
| NaCl | 6800.00 | 8000.00 |
| NaH2PO4•H2O | 140.00 | - |
| Na2HPO4 (anhydrous) | - | 47.50 |
| amino acids | ||
|---|---|---|
| L-Arginine•HCl | 21.00 | 21.06 |
| L-Cystine•2HCl | 15.65 | 15.55 |
| L-Glutamine | 292.30 | 292.30 |
| L-Histidine•HCl•H2O | 15.00 | 10.50 |
| L-Isoleucine | 26.00 | 26.23 |
| L-Leucine | 26.00 | 26.23 |
| L-Lysine•HCl | 36.47 | 36.53 |
| L-Methionine | 7.50 | 7.46 |
| L-Phenylalanine | 16.50 | 16.51 |
| L-Threonine | 24.00 | 23.82 |
| L-Tryptophan | 4.00 | 4.08 |
| L-Tyrosine•2Na•2H2O | 25.95 | 26.11 |
| L-Valine | 23.50 | 23.43 |
| vitamins | ||
| Biotin | 1.00 | 1.00 |
| D-Calcium pantothenate | 1.00 | 1.00 |
| Choline chloride | 1.00 | 1.00 |
| Folic acid | 1.00 | 1.00 |
| i-Inositol | 2.00 | 2.00 |
| Nicotinamide | 1.00 | 1.00 |
| Pyridoxine•HCl | 1.00 | 1.00 |
| Riboflavin | 0.10 | 0.10 |
| Thiamine•HCl | 1.00 | 1.00 |
| other | ||
| D-Glucose | 1000.00 | 1000.00 |
| Phenol red, Na | 10.00 | 17.00 |
| add | ||
| NaHCO3
Powder (g/L) 7.5% Solution (mL/L) |
2.20
29.40 |
2.20
29.40 |
| specifications | ||
| pH (before buffer) | 5.7±0.5 | 6.5±0.5 |
| pH (after buffer) | 7.5±0.2 | 7.3±0.5 |
| Osmolality (mOsm) | 285±15 | 296±30 |
| Grams of powder required to prepare 1L (1X Solution) | 9.19 | 10.30 |
| 1xN/2 | stromal cell
line, dependent on IL-7 |
| 2D6 | bioassays
of
murine IL-12 |
| 2D9 | detection of IFN-g |
| 2E8 | detection of human IL-7 |
| 3B6 | producer of ADF , thioredoxin ; see: 3B6-IL1 |
| 3T3 | assays of TGF , PDGF ; producer of HBGF |
| 4-1.10 | resistant against OsM growth inhibition |
| 7TD1 | detection of IL-6 |
| 32D | detection of IL-3 |
| 32D-G | detection of G-CSF |
| 32D-Epo | detection of Epo |
| 32D-GM | detection of GM-CSF |
| 47.10 | factor-dependent cell line yielding HPP-CFC |
| 5637 | Conditioned medium yields general purpose cytokine cocktail |
| A9.12 | detection of IL-2 |
| A375 | detection of IL1
,OsM
,
IL-6 |
| A431 | detection of EGF |
| A2058 | AMF producer |
| AC6.21 | murine stromal cell line |
| AG-F | high level secretion of IL-6 |
| AGM-S3 | stromal cell line |
| AKR-2B | detection of TGF-a,
TGF-b |
| AML-193 | detection of IL-3 |
| ANBL-6 | IL-6 |
| AP-16 | dependent on EGF |
| AS-E2 | strictly dependent on Epo |
| ATH8 | dependent on IL-2 |
| B6SUt-A | dependent on murine IL-3 |
| B9 | detection of murine, rat and human IL-6 |
| B9-11 | detection of human IL-11 |
| B9-1-3 | detection of human IL-13 |
| B9-TY1 | dependent on IL-11 |
| B10 | see: JR-2-82 |
| B13 | detection of murine IL-5 |
| BAC1.2F5 | detection of CSF-1 / M-CSF |
| BaF3 | detection of murine IL-3 |
| BALM-4 | detection of IL-4 |
| BC-1 | IL-10 |
| BCBL-1 | IL-10 |
| BCL1 is a cell line established from a spontaneous lymphoma obtained from a female BALB/c mouse. This murine B-lineage leukemia has many features of human chronic lymphocytic leukemia (CLL). Cells are passaged as splenic tumors in vivo and isolated from the tumor by Ficoll gradient centrifugation and depletion of T-cells with monoclonal antibodies. In vitro the cell line can be induced by bacterial endotoxins to produce IgM. The cells express IgM and also IgD on the cell surface. Proliferation of the BCL1 B cell lymphoma induced by IL-4 and IL-5 is dependent on IL-6 and GM-CSFref. The IL-5 induced proliferation of the cells is abrogated by TGF-b and to a lesser extent by IFN-g. IL-5 activity is determined by measuring the incorporation of 3H-thymidine into the newly synthesized DNA of the proliferating factor-dependent cells. Cell proliferation can be determined also by employing the MTT assay. An alternative and entirely different method of detecting IL-5 is RT-PCR quantitation of cytokines. The lymphokines IL-1, IL-2 , IL-3, and IL-6 have no effect on the growth of BCL1ref. BCL1 cells are approximately 1000-fold less sensitive for human IL-5, which is therefore detected by employing the TF-1 cell line. BCL1 cells also constitutively secrete IL-10 into the conditioned mediumref1,ref2,ref3,ref4,ref5 | detection of IL-5 |
| baby hamster kidney (BHK) | production of recombinant cytokines |
| BON | multiple autocrine
loops
involving IGF-1 |
| BT-20 | detection of bFGF
,
GM-CSF |
| Caco-2 (human colon carcinoma) | |
| CCL-39 | respond to a-thrombin, bFGF
,
aFGF
,
insulin,
EGF |
| CCL-64 | detection of TGF-b |
| CCL-185 | detection of IL-4 |
| CESS | detection of BCDF,
TRF
,
IL-6 |
| Chinese hamster ovary (CHO) : fibroblasts isolated from the ovary of a spontaneous aneuploid mutant Chinese hamster (Cricetulus griseus) | production of recombinant cytokines |
| CRL 1395 | detection of bFGF |
| CSN/70 | a subline of Namalwa cells |
| CT.4S | detection of IL-4 |
| CT6 | detection of IL-2 |
| CTL44 | detection of murine IL-4 |
| CTLL-2 | detection of IL-2 |
| D1.1 | a subclone of Jurkat cells constitutively expressing 5c8 |
| D10 | detection of IL1 |
| D10S | see: D10 |
| D36 | detection of human IL-10 |
| Da | detection of LIF |
| DAUDI | detection of IFN-a |
| DMS 53 | secretion of calcitonin, ACTH , GH and others |
| DMS 79 | secretion of calcitonin, ACTH
,
POMC
,
VEGF-A |
| DS-1 | detection of human, not murine IL-6 |
| DW34 | detection of IL-7 |
| Ea3.17 | detection of murine IL-3 |
| EB-PE | autocrine regulation by bFGF |
| EL4 | detection of IL1 |
| EML C1 | dependent on SCF |
| ES-OMC-MN | IL-6 |
| FBHE | detection of aFGF , bFGF |
| FDCPmix | detection of CSF
,
IL-3 |
| FDCP1 | detection of CSF
,
IL-3 |
| FDCP2 | detection of IL-2 |
| FLS4.1 | stromal cell line |
| FL5.12 | IL-3 |
| FS-1 | stromal cell line |
| GF-D8 | detection of GM-CSF |
| GM/SO | detection of GM-CSF |
| GNFS-60 | detection of G-CSF |
| GS-9L | production of VEGF-A |
| HAS303 | stromal cell line |
| HCD57 | detection of Epo |
| human embryonic kidney (HEK293) | heterologous gene expression ; studies of cytokine receptor physiology and signaling |
| HepG2 | detection of IL-6 |
| HFB-1 | detection of BCDF |
| HKB-1 | producer of IL-6 |
| HL-60 | detection of IFN-g |
| HSG | studies with EGF |
| HT-2 | detection of human IL-2 |
| HT55 | detection of scatter factor , HGF |
| HT115 | detection of scatter factor , HGF |
| HTB-9 | see: 5637 |
| HuGC-OOHIRA | secretes very high amounts of G-CSF |
| IC-2 | detection of IL-3 |
| INA-6 | dependent on IL-6 |
| IPN/45 | a subline of Namalwa cells |
| J774 | detection of CSF-1 / M-CSF |
| JR-2-82 and D3 | detection of BCDF |
| Jurkat (JK) | IL-2 |
| K-4 | see: LyD9 |
| K-5 | see: LyD9 |
| K-119 | G-CSF |
| KD83 | detection of murine and human IL-6 |
| KG-1 | detection of CSF
,
TGF-b |
| KG1a | see: KG-1 |
| K-GM | see: LyD9 |
| Kit225 | detection of IL-2 |
| KM102 | stromal cell line |
| KMT-2 | detection of IL-3 |
| KN2 | a subline of Namalwa cells |
| KPB-M15 | constitutive production of SCGF
,
CSF-1
/ M-CSF |
| KPL-4 | high level IL-6 |
| KPMM2 | IL-6 |
| KT-3 | detection of IL-2 |
| KU-19-19 | producer of G-CSF |
| KU-19-20 | producer of GM-CSF |
| KYM-1D4 | detection of TNF-a |
| L4 | detection of BCDF
,
IL-4 |
| L87/4 | stromal cell line |
| L88/5 | see: L87/4 |
| L138.8A | detection of IL-3 |
| L929 | detection of TNF-a |
| LA7 | used as feeder cells for mammary epithelial cells |
| LBRM-33 | detection of IL1 |
| LBRM-TG6 | see: LBRM-33 |
| L-M | detection of TNF-a |
| LS-1 | see: LyD9 |
| LT-1 | genetically engineered IL-4 |
| LyD9 | detection of IL-3 |
| M1 | detection of LIF |
| MaMi | constitutive production of IL-6 |
| MC3T3-G2/PA6 | see: PA6 . Stromal cell line |
| MC/9 | detection of IL-3 |
| MC/9.IL4 | See: MC/9 |
| MCF-7 | human mammary carcinoma cell line IGF |
| MD10 | see: D10 |
| MDBK | detection of IFN-a |
| MEB5 | multipotent neural stem cell line dependent on EGF |
| MH11 | detection of IL-7 |
| MH60-BSF-2 | detection of IL-6 |
| MLA-144 | detection of IL-2 |
| MM5.1 | study of Hematopoiesis |
| MM5.2 | see: MM5.1 |
| MO7E | detection of IL-3 |
| Mono Mac 6 | detection of IL-1b |
| Merwin plasma cell (MPC-11) | detection of human Activin A |
| MRL104.8a | stromal cell line |
| MS-5 | murine stromal cell line |
| MV-3D9 | detection of TGF-beta |
| Na1 | source of BGDF |
| Namalwa | production of recombinant cytokines |
| Nb2 | detection of human IL-7 |
| NBFL | detection of CNTF
,
LIF |
| NFS-60 | detection of murine G-CSF |
| NIM-1 | study of Hematopoiesis |
| NKC3 | detection of IL-2 |
| NOB-1 | see: EL4 |
| NRK-49F | detection of TGF |
| OH-2 | multi-responsive to cytokines
;
IL-6 |
| OCI/AML1a | detection of G-CSF |
| OP9 | stromal cell line |
| OTT1 | transfected with IL-1a |
| PA6 | see: PA6 . Stromal cell line |
| PC12 | detection of NGF |
| PIL-6 | detection of murine IL-6 |
| PK-2 | stromal cell line |
| PK15 | detection of murine, porcine, bovine, human TNF-a |
| PNT | a subline of Namalwa cells |
| PT-18 | detection of IL-3 |
| PU-34 | stromal cell line |
| Ramos | detection of IL-4 |
| RAW264.7 | detection of murine IFN-g |
| RINm5F | detection of murine and human IL-1a |
| RPMI 1788 | detection of IL1 |
| S21 | A variant of BaF3
;
requires a stromal
cell line and no IL-3 |
| Saka | stromal cell line |
| SAS-1 | dependent on GM-CSF |
| SCL1-24 | stromal cell line |
| SC-MSC | stromal cell line |
| Sez627 | detection of human IL-2 |
| SKW6-Cl4 | detection of BCDF , TRF |
| SPY3-2 | stromal cell line |
| SR-4987 | stromal cell line ; detection of human and bovine bFGF |
| SSL 1 | stromal cell line |
| ST-1 | stromal cell line |
| ST2 | murine stromal cell line |
| SUM-52PE | overexpression of FGF-1 and FGF-7 receptors |
| SW-13 | detection of aFGF , bFGF , IL1 , TGF ; secretion of various cytokines |
| T10 | detection of IL-11 |
| T88 | detection of IL-5 |
| T88-M | detection of IL-3 |
| T1165 | detection of IL-6 |
| TALL-103 | detection of GM-CSF |
| TBR59 | stromal cell line |
| TCL-1 | CSF-1 / M-CSF |
| TF-1 | detection of IL-3 |
| THS119 | growth dependent on stromal cell line |
| TMD2 | detection of IL-3 |
| TS1 | detection of IL-9 |
| TSGH9201 | dependent on EGF |
| U937 | |
| UG3 | study of molecular differentiation events in Hematopoiesis |
| U2-OS | study of Hematopoiesis , constitutive producer of TGF-b |
| UT-7 | detection of Epo |
| UT-7/Epo | see: UT-7 |
| UT-7/GM | see: UT-7 |
| UT-7/TPO | see: UT-7 |
| UTMC-2 | IL-6 |
| WEHI-3B | detection of IL-6 |
| WEHI-164 | see: WEHI-3B |
| WISH | detection of IFN-a |
| XG-1 | detection of IL-6 |
| Y16 | detection of IL-5 |
| YAC-1 | measurement of activities of LAK cells |
| YAPC | dependent on IL-1a |
| YS-PPB | pre-pro-B-cell line independent of IL-7 |
| YT | constitutive production of perforins
,
IL-10 |
| Z-33 | GM-CSF |
|
|
|
|
|
| look |
|
|
|
| WBCs |
|
|
|
| quantity |
|
|
|
| consistence |
|
|
|
| PMN |
|
|
|
| proteins |
|
||
| LDH |
|
||
| glucose |
|
The culture of animal cells is key to much of basic research today and
an important starting point for therapeutic applications. But each cell
type has its own quirks. Some cells are happy with most media and protocols,
but others can become the bane of a scientist's existence with their seemingly
inexplicable needs. Caitlin Smith reports. The RCMW Perfused Flow System
showing various culture chamber options. (Courtesy of Synthecon, Inc.)
:
Why some cells start to grow and others do not, we do not know : some
scientists believe in adding various supplements, but my guess is that
if cells start to grow autonomously, they grow with or without these supplements—but
people, including scientists, are superstitious. Most scientists would
balk at the notion of superstition in their protocols, and yet desperate
times often call for 'whatever works' measures. This article will focus
on some peculiarities and potential remedies of culturing three cell types
that challenge researchers today: primary, stem and hybridoma cells. Most
primary cells are particularly difficult to grow. Once established as cell
lines, they become much easier to grow, especially transformed (tumorized)
lines. So the difficulty in growing them is typically prior to transformation.
The primary culture of animal cells has long been a challenge to cell culturists.
Thankfully, there are some media additives that seem to benefit most cultures,
such as different types of sera and growth factors. Take human skin cells
for example : peptide additives (for example, EGF, insulin and bFGF) are
important for culturing both keratinocytes and melanocytes. He uses medium
with <0.1 mM calcium to prevent differentiation and prolong proliferative
growth. Often one must use the 'try-it-and-see' approach for different
additives. Whereas they have little trouble growing cultures of melanoma
cells from advanced lesions and metastases, they have difficulties growing
melanoma cells from very early primary lesions. The problem is that their
exact growth factor requirements are simply not known. Further complicating
matters is the exasperating fact that not all cell types respond to additives
in the same way. Very often the factors that stimulate the normal cells
actually inhibit the malignant cells. We need to perform very meticulous
testing to identify the components that can support the proliferation of
these primary melanoma cells. This is critical for understanding early
changes from normal to malignancy. One of the problems that we face is
the paradox that in a tumor specimen, the untransformed cell contaminants
will outgrow the tumor : almost all malignant cell cultures grow extremely
slowly at first, and often our biggest challenges are preventing normal
cell overgrowth and/or contamination. To counteract this effect, some groups
grow cultures in the absence of fetal calf serum, which is not as big a
handicap as it might sound. Serum often favors the growth of normal cells
over malignant cells, compounding the problem of normal cells outgrowing
malignant cells.
Manufacturing of Cell Culture Technologies' media at B. Braun Medical
AG, Crissier/Lausanne, Switzerland. (Courtesy of Cell Culture Technologies,
LLC.)
Some cells in primary culture grow better when provided with so-called
'solid phase cues', or a three-dimensional (3D) environment that favors
cell growth. A future challenge is going from 2D to 3D cultures : there
is some beautiful work out there showing that any number of basic cellular
properties are altered when the cells are cultured in three versus two
dimensions. While it is impossible to know the exact matrix conditions
in vivo, many companies offer matrix or chamber products that claim to
better replicate the 3D in vivo environment—for example, Chemicon's 3D
Cell Culture Kit, 3DM's Puramatrix,
and Oligene's Perfusion
Chamber System PCS 3c. The importance of '3D biology' has only recently
started to be fully understood and appreciated : Synthecon offers the National
Aeronautics and Space Administration (NASA)-designed Rotary
Cell Culture System, a bioreactor capable of growing 3D cultures. As
a type of primary cell, stem cells are in a category all their own. Whereas
their pluripotency has earned them fame and controversy, there is a long
way to go before their enormous therapeutic potential is realized. Once
the stem cells of interest are isolated, they can be quite difficult to
establish in culture and to grow thereafter. Sometimes they simply die
after isolation, and one must do a protocol optimization to overcome this
if it presents too much of a problem. Since isolation protocols are lengthy,
the optimization would be as well. Once cultures are established, scientists
growing human embryonic stem (ES) cells need to prevent stock cultures
from differentiating into the over 200 cell types that they can become.
Typically ES cells require a medium supplemented with serum and are grown
on a feeder layer of mouse fibroblasts, which helps to keep the stem cells
in their undifferentiated state. This arrangement is less than ideal for
clinical research purposes, because the presence of animal contaminants
in the medium and the feeder layer can make it unsafe for future therapeutic
applications in humans. To alleviate the problem, the feeder cell layer
is often replaced by a mouse-derived cell matrix extract (such as Matrigel
from BD Biosciences) in combination with conditioned medium from a mouse
fibroblast culture. Similarly, the animal serum can be replaced by a serum-replacement
formulation (such as Knockout
Serum Replacement from Invitrogen). But these tricks do not solve the
problem of animal contaminants. A substantial challenge in the near future
will be the development of serum-, feeder- and protein substrate-free cultures
for growing stem and other cell types. An important step in this direction
was taken in March when 2 independent groups reported that a specific formulation
of growth factors can block differentiation and replace mouse fibroblast
conditioned media for the culture of human ES cellsref1,
ref2.
Whereas this discovery will go a long way toward making the use of ES cell
cultures safer for clinical use, it does not mean that the culture media
are yet free of animal components: a bovine-derived serum replacement and
a mouse-derived matrix gel are still required. After successfully isolating
and maintaining your stem cell of interest, you may want to induce differentiation.
R&D Systems offers kits
to facilitate the differentiation of ES cells into dopaminergic neurons
and oligodendrocytes under serum-free conditions. The kits contain supplements
to enrich neural stem cell populations; bovine fibronectin as a matrix
for cell attachment and spreading; and the basic human fibroblast growth
factor, mouse fibroblast growth factor 8b and mouse sonic hedgehog amino-terminal
peptide (for dopaminergic neurons), or human epidermal growth factor and
human platelet-derived growth factor AA (for oligodendrocytes). R&D
Systems estimates that the kit contents are sufficient for the differentiation
of 3 x 107 ES cells. Monoclonal antibodies, whose value in basic
research is undisputed, are produced from hybridomas, immortalized cell
hybrids resulting from the fusion of spleen cells from an immunized mouse
with a continuous myeloma cell line. Hybridomas are traditionally grown
in medium supplemented with bovine serum, but as with stem cells, a recent
challenge has been the need to grow them in serum-free medium with no animal
proteins. The issue arises from the fact that monoclonal antibodies are
increasingly useful as human therapeutic agents. Manufacturers are beginning
to fill this need for serum-free medium. The most important improvement
we've seen is the development of better commercially available serum-free
media, but a challenge remains to develop robust animal component-free
medium that is equivalent to serum-containing medium. Serum is expensive,
so animal component-free medium needs to be less expensive yet be suitable
for several cell types. Cross-section through hollow fiber culture system
showing extracapillary space. (Courtesy of FiberCell Systems, Inc.) :
For example, Cell Culture Technologies offers their TurboDoma
media for culturing myeloma and hybridoma cell lines, as well as kits
aimed at saving researchers' time. They offer chemically defined, protein-
and peptide-free minimal culture media for growing well-established animal
cell lines. All their media are made of pharmaceutical-grade small molecules
of nonanimal origin. They do not use complex additives such as hydrolysates,
yeast extracts, albumins or proteins, not even insulin, to produce our
culture media. For scientists wanting a quick start to serum-free culture,
Cell Culture Technologies also offers Starter
Kits containing a hybridoma cell line grown in the absence of animal
proteins, in minimal culture medium free of proteins and peptides, and
protocols from the European Collection of Cell Cultures for maintenance
and banking of the cell line. Today, too many scientists in academia and
industry waste too much time selecting cells for serum-free culture, so
we thought that providing the essential tools at once might help scientists
to concentrate on their actual research targets instead of wasting time
with boring selection procedures. Maximizing antibody production is an
important goal in growing hybridomas, and the culture vessel may have an
effect on cell growth and monoclonal antibody output. FiberCell Systems
claims that hybridomas grow exceptionally well in their proprietary hollow
fiber cells. Because of the tremendous amount of surface area offered in
such a small volume, and the high gross filtration rate of our proprietary
fiber, cells will grow at extremely high densities. This permits easy adaptation
to serum-free medium or the reduction of serum to as low as 2% of the total
volume of the medium with no problems. Another advantage to their system
is that their fiber allows transforming growth factor , a secreted factor
inhibitory to hybridoma growth, to diffuse away while retaining the antibodies
in the small volume of the extracellular space. Hybridomas grown in their
fiber cell systems can produce up to 2 grams of monoclonal antibody per
month. FiberCell's hollow fiber cell culture system. (Courtesy of FiberCell
Systems, Inc.)
Whereas great strides have been made in cell culture technology, there
remain even greater challenges to the field in the near future. For example,
the importance of tracking karyotypic changes has received too little attention.
Cultured cells are continuously under selection pressure. Only those with
selection advantages will survive and expand. To track and maintain the
karyotypes of each specific cell type is vital for the usefulness of the
cells in research. In the culture of primary cells, Halaban says that continuing
to identify growth factors that stimulate proliferation and differentiation
is an important technical challenge. In addition, she suggests the creation
of government-supported centers of excellence that distribute cells to
researchers for a nominal fee. Growing human cells is very critical for
continuing research. It takes specialized skills that cannot be developed
by every scientist. Cell culture is transitioning from being merely"a supporting
technique to a biotechnology. Despite the current development of new tools
in cell culture, she believes that the key to optimizing cell culture is
rooted in cell biology. Scientists involved in the optimization of cell
culture systems (irrespective of their application) need to focus on understanding
the biology of cells in order to achieve their goal.

|
|
|
|
|